Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

International Journal of Radiation Oncology*Biology*Physics

Topics

Medicine

Cancer Oncology

Internal Medicine

Urology

Gastroenterology

Show all topics

DOI

10.1016/j.ijrobp.2004.06.260